Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $12.84 USD
Change Today +0.07 / 0.55%
Volume 241.6K
PETX On Other Exchanges
As of 8:10 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Donald E. Stitzenberg

Vice President of Manufacturing, Aratana Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 60 board members in 2 different organizations across 2 different industries.

See Board Relationships


Mr. Donald E. Stitzenberg has been Vice President of Manufacturing at Aratana Therapeutics, Inc. since February 12, 2013. Mr. Stitzenberg is the Founder of Carnegie Business Associates. Mr. Stitzenberg serves as Vice President of Global Supply Chain at Merial Limited. He spent 33 years in executive positions at Merck and Co., Inc. in marketing, research, planning and manufacturing. He served as Executive Director of Planning for Merck where he led the formation of Merck ...

Read Full Background

Corporate Headquarters*

1901 Olathe Boulevard
Kansas City, Kansas 66103

United States

Phone: 913-353-1000
Fax: 913-904-9641

Board Members Memberships*

Member of Board of Trustees
Member of The Board of Visitors


There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PETX:US $12.84 USD +0.07


Richard Chin M.D.Co-Founder, Chief Executive Officer, President and Director
Kindred Biosciences, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARATANA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at